ERBB2 and breast carcinoma: Among newly diagnosed breast cancer patients, IMLN metastasis is associated with age, tumor location/depth, and the tumor’s expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER-2) [2, 9, 40, 50, 80–85].